Int'l Neuroblastoma Webinar Series Session #19: SIOPEN Clinical Trials Update with Dr. Lucas Moreno

A clinical trials update from the SIOPEN research network, featuring Dr. Lucas Moreno of Vall d'Hebron University Hospital in Barcelona. In Session #19 of our global Neuroblastoma Webinar Series, Dr. Moreno shares the latest on active and emerging trials across SIOPEN—a European network connecting centers from more than 25 countries. He discusses how these international trials are coordinated, provides a plain-language update on current studies including the BEACON program, explains what shapes eligibility and participation, and explores how families and care teams can evaluate trial pathways together. The session closes with a live audience Q&A. Designed for both families and professionals, this conversation offers practical insight into the evolving neuroblastoma treatment landscape and what it means for children facing the disease today. In this session: How SIOPEN brings centers across Europe and beyond together to run neuroblastoma clinical trials A plain-language overview of active and emerging studies, including the BEACON program What influences trial eligibility and participation Key considerations when families and care teams evaluate trial options together Live Q&A with Dr. Moreno About the speaker: Dr. Lucas Moreno is the President of SIOPEN and a leading pediatric oncologist at Vall d'Hebron University Hospital in Barcelona. Explore more: 🎥 Watch past and upcoming sessions: https://neuroblastomaday.org/global-webinar 💙 Learn about Shir for Life: neuroblastomaday.org Register for the next session: https://neuroblastomaday.org/webinar